Creative Financial Designs’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.6K Hold
170
﹤0.01% 1316
2025
Q4
$14.5K Hold
170
﹤0.01% 1248
2025
Q3
$13.2K Sell
170
-138
-45% -$10.8K ﹤0.01% 1288
2025
Q2
$24.1K Buy
308
+5
+2% +$373 ﹤0.01% 1079
2025
Q1
$22K Hold
303
﹤0.01% 1059
2024
Q4
$22.4K Sell
303
-206
-40% -$14.4K ﹤0.01% 1018
2024
Q3
$33.6K Sell
509
-141
-22% -$10.2K ﹤0.01% 906
2024
Q2
$60K Buy
650
+107
+20% +$9.47K 0.01% 710
2024
Q1
$51.9K Buy
543
+73
+16% +$6.13K ﹤0.01% 720
2023
Q4
$35.8K Hold
470
﹤0.01% 757
2023
Q3
$32.6K Buy
470
+41
+10% +$3.29K ﹤0.01% 736
2023
Q2
$40.5K Buy
429
+262
+157% +$22.8K ﹤0.01% 683
2023
Q1
$13.8K Buy
+167
New +$13.1K ﹤0.01% 892
2022
Q4
Sell
-180
Closed -$15K 1316
2022
Q3
$15K Hold
180
﹤0.01% 794
2022
Q2
$17K Hold
180
﹤0.01% 766
2022
Q1
$21K Buy
+180
New +$20.2K ﹤0.01% 752
2021
Q4
Sell
-612
Closed -$69K 1282
2021
Q3
$69K Hold
612
0.01% 530
2021
Q2
$63K Hold
612
0.01% 543
2021
Q1
$51K Hold
612
0.01% 558
2020
Q4
$56K Hold
612
0.01% 486
2020
Q3
$49K Hold
612
0.01% 466
2020
Q2
$42K Buy
+612
New +$43.5K 0.01% 449

Other funds holding EW

Creative Financial Designs's EW Position: Q1 2026 in Review

Creative Financial Designs held its Edwards Lifesciences (EW) position steady in Q1 2026 at 170 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1316.

Creative Financial Designs first reported a position in EW in Q2 2020 and has held it in 22 quarters since. The position peaked at $69K in Q3 2021. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Creative Financial Designs held 170 shares of Edwards Lifesciences worth $13.6K as of Q1 2026.
  • Creative Financial Designs left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up ﹤0.01% of Creative Financial Designs's portfolio in Q1 2026, its #1316 holding.
  • Creative Financial Designs first reported a position in Edwards Lifesciences in Q2 2020 and has held it in 22 quarters since.
  • Creative Financial Designs's Edwards Lifesciences position peaked at $69K in Q3 2021.
  • 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Creative Financial Designs's 13F filing for Q1 2026, filed 13 Apr 2026.